Patents by Inventor Berke Cagkan TOPTAS

Berke Cagkan TOPTAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS OF DEVELOPING DISEASE ASSOCIATED ANTIBODY SEQUENCES
    Publication number: 20250104804
    Abstract: The disclosure herein relates to in silico methods for reconstructing complete polypeptide and nucleic acid consensus sequences for novel biologically active protein dimers, including but not limited to antibodies that are useful for the treatment and diagnosis of a cancer, autoimmune condition, or infectious disease.
    Type: Application
    Filed: December 6, 2021
    Publication date: March 27, 2025
    Inventors: Daniele Biasci, Ines De Santiago Domingos De Jesus, Berke Cagkan Toptas, Goran Rakocevic
  • CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
    Publication number: 20250092155
    Abstract: The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
    Type: Application
    Filed: September 23, 2024
    Publication date: March 20, 2025
    Inventors: Daniele Biasci, Goran Rakocevic, Berke Cagkan Toptas, Ines De Santiago Domingos De Jesus
  • Cancer associated antibody compositions and methods of use
    Patent number: 12134655
    Abstract: The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: November 5, 2024
    Assignee: ABSCI CORPORATION
    Inventors: Daniele Biasci, Goran Rakocevic, Berke Cagkan Toptas, Ines De Santiago Domingos De Jesus
  • CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
    Publication number: 20220204643
    Abstract: The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
    Type: Application
    Filed: April 29, 2020
    Publication date: June 30, 2022
    Inventors: Daniele Biasci, Goran Rakocevic, Berke Cagkan Toptas, Ines De Santiago Domingos De Jesus
  • CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
    Publication number: 20220031841
    Abstract: The disclosure herein relates to novel cancer-associated antibodies that are used in the treatment and diagnosis of a cancer. The complete polypeptide and nucleic acid consensus sequences of the antibodies disclosed herein are reconstructed in silico.
    Type: Application
    Filed: September 19, 2019
    Publication date: February 3, 2022
    Inventors: Daniele BIASCI, Ines de Santiago Domingos de JESUS, Berke Cagkan TOPTAS